INCOME STATEMENT (Quarterly GAAP In millions $) |
(Sep 30 2023) III. Quarter |
(Jun 30 2023) II. Quarter |
(Mar 31 2023) I. Quarter |
(Dec 31 2022) IV. Quarter |
(Sep 30 2022) III. Quarter |
Revenue From Contract With Customer Including Assessed Tax |
141.19 |
159.17 |
182.66 |
|
200.74 |
Revenue From Contract With Customer Including Assessed Tax |
- |
- |
- |
|
- |
Total Revenue |
141.19 |
159.17 |
182.66 |
186.76 |
200.74 |
Cost of Goods and Services Sold |
104.63 |
79.31 |
81.85 |
90.70 |
86.51 |
Gross
Profit |
36.56 |
79.86 |
100.82 |
96.06 |
114.23 |
Selling, Administration, Marketing |
55.47 |
48.97 |
56.17 |
53.24 |
53.64 |
Depriciation & Amortization |
- |
- |
- |
- |
- |
Research and Development Expense |
10.58 |
9.71 |
12.15 |
11.11 |
10.23 |
Restructuring, Accretion & impairment charges |
- |
- |
- |
- |
- |
Other operatinig exp. /-income |
0.00 |
0.00 |
- |
- |
0.00 |
Unusual Expense /-Income |
- |
- |
- |
- |
- |
Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability |
-34.29 |
1.79 |
1.24 |
- |
- |
Contingent Consideration Expense |
- |
- |
- |
-17.13 |
-2.31 |
Total operating costs including COS |
136.38 |
139.77 |
151.40 |
137.93 |
148.08 |
Operating income/-loss
|
4.81 |
19.40 |
31.26 |
48.84 |
52.67 |
Other Deductions / - Income |
Interest expense |
0.27 |
0.27 |
0.27 |
0.27 |
0.33 |
Interest income |
- |
- |
- |
- |
- |
Net interest expense/-income |
0.27 |
0.27 |
0.27 |
0.27 |
0.33 |
Investment Income, Net |
- |
- |
- |
- |
- |
Foreign Currency Transaction (Gain) Loss |
- |
- |
- |
- |
- |
Allowances, Health Care Trust Fund And Other |
- |
- |
- |
- |
- |
Unexpected (Gain) Loss |
- |
- |
- |
- |
- |
Other loss/ -income |
-7.10 |
-6.04 |
-5.11 |
-4.42 |
5.32 |
Amortization Of Debt Issuance Cost |
- |
- |
- |
- |
-0.46 |
Total costs & expenses |
129.56 |
134.01 |
146.57 |
133.78 |
153.27 |
Income /-loss before income taxes |
11.64 |
25.16 |
36.09 |
52.99 |
47.47 |
Income taxes expenses/-benefit |
-6.54 |
5.10 |
7.26 |
4.26 |
7.06 |
Income after income taxes |
18.17 |
20.06 |
28.83 |
48.73 |
40.41 |
Net income/-loss
of other equity |
- |
- |
- |
- |
- |
Income/-loss
from cont. Ops. |
18.17 |
20.06 |
28.83 |
48.73 |
40.41 |
Accounting change |
- |
- |
- |
- |
- |
Discontinued operations |
- |
- |
- |
- |
- |
Extraordinary items |
- |
- |
- |
- |
- |
Net Income/-loss |
18.17 |
20.06 |
28.83 |
48.73 |
40.41 |
Noncontrolling interests |
- |
- |
- |
- |
- |
Prefered dividends |
- |
- |
- |
- |
- |
Other |
- |
- |
- |
- |
- |
Income/-loss to shareholder |
18.17 |
20.06 |
28.83 |
48.73 |
40.41 |
EBIT |
11.91 |
25.43 |
36.36 |
53.26 |
47.80 |
EBITD |
31.61 |
41.42 |
51.61 |
67.64 |
60.47 |
EBITDA |
32.07 |
41.88 |
52.07 |
68.09 |
60.92 |